GOLD and the fixed ratio

GOLD and the fixed ratio Letter (1038) Total Article Views Authors: Vestbo J Published Date September 2012 Volume 2012:7 Pages 663 - 665 DOI: http://dx.doi.org/10.2147/COPD.S35769 Received: 09 July 2012 Accepted: 09 July 2012 Published: 25 September 2012 J rgen Vestbo University of Manchester, Manchester, UK I read with interest the paper entitled "Diagnosis of airway obstruction in the elderly: contribution of the SARA study" by Sorino et al in a recent issue of this journal.1 Being involved in the Global Initiative for Obstructive Lung Diseases (GOLD), it is nice to see the interest sparked by the GOLD strategy document. However, in the paper by Sorino et al, there are a few misunderstandings around GOLD and the fixed ratio (forced expiratory volume in 1 second/forced volume vital capacity < 0.70) that need clarification. View original paper by Sorino and colleagues. Post to: Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter Readers of this article also read: Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors Amino acid management of Parkinson’s disease: a case study Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and meta-analysis Exacerbation frequency and course of COPD Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement The search for common pathways underlying asthma and COPD